FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Rudwaleit

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
In-Ho Song; Anja Weiß; Christian E Althoff; Bruce Freundlich; Hildrun Haibel; Kay-Geert A Hermann; Ekkehard Lange; Joachim Listing; Denis Poddubnyy; Martin Rudwaleit; Joachim Sieper
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Christian E Althoff; Torsten Diekhoff; Bruce Freundlich; Hildrun Haibel; Bernd Hamm; Martin Rudwaleit; Joachim Sieper; In-Ho Song; Anja Weiß; Kay-Geert A Hermann
Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
Martin Rudwaleit
The impact of cohort studies in spondyloarthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Rudwaleit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: In-Ho Song; Anja Weiß; Christian E Althoff; Bruce Freundlich; Hildrun Haibel; Kay-Geert A Hermann; Ekkehard Lange; Joachim Listing; Denis Poddubnyy; Martin Rudwaleit; Joachim Sieper
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Annals of the rheumatic diseases 2013;72(6):823-5.
2013: Christian E Althoff; Torsten Diekhoff; Bruce Freundlich; Hildrun Haibel; Bernd Hamm; Martin Rudwaleit; Joachim Sieper; In-Ho Song; Anja Weiß; Kay-Geert A Hermann
Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
Annals of the rheumatic diseases 2013;72(6):967-73.
2013: Martin Rudwaleit
The impact of cohort studies in spondyloarthritis.
Joint, bone, spine : revue du rhumatisme 2013;80(2):127-9.
2013: In-Ho Song; Heiner Appel; Jürgen Braun; Iris Haug-Rost; Frank Heldmann; Joachim Listing; Martin Rudwaleit; Joachim Sieper
One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare.
Annals of the rheumatic diseases 2013;72(2):305-6.
2012: Denis Poddubnyy; Martin Rudwaleit; In-Ho Song; Inge Spiller; Janis Vahldiek; Henning Brandt; Joachim Sieper
The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic.
Annals of the rheumatic diseases 2012;71(12):1998-2001.
2012: In-Ho Song; Elke S Stelling; Hildrun Haibel; Joachim Sieper; Martin Rudwaleit
Evaluation of the spinal pain score in AS--a psychometric analysis.
Rheumatology (Oxford, England) 2012;51(12):2155-63.
2012: Denis Poddubnyy; Martin Rudwaleit; Henning Zeidler; Jürgen Braun; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Joachim Sieper
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
Annals of the rheumatic diseases 2012;71(10):1616-22.
2012: Kay-Geert A Hermann; Anne Grethe Jurik; Robert Landewé; Helena Marzo-Ortega; Mikkel Østergaard; Martin Rudwaleit; Joachim Sieper; Désirée M F M van der Heijde; Xenofon Baraliakos; Jürgen Braun
Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group.
Annals of the rheumatic diseases 2012;71(8):1278-88.
2012: In-Ho Song; Anja Weiß; Christian E Althoff; Martin Bohl-Bühler; Gerd R Burmester; Svetlana Djacenko; Bruce Freundlich; Hildrun Haibel; Kay-Geert A Hermann; Joachim Listing; Denis Poddubnyy; Martin Rudwaleit; Joachim Sieper
Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.
Annals of the rheumatic diseases 2012;71(7):1212-5.
2012: Thomas Häupl; B Hoppe; Joachim Listing; B Ostendorf; Martin Rudwaleit; Hendrik Schulze-Koops; Joachim Sieper; Alla Skapenko; Karl Skriner; T Sörensen; Bruno Stuhlmüller; Angela Zink; Heiner Appel; Marina Backhaus; H Burkhardt; M Grünke; Andreas Grützkau; Gerd R Burmester
[Biomarkers in rheumatology. Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research].
Zeitschrift für Rheumatologie 2012;71(4):314-8.
2012: Denis Poddubnyy; Martin Rudwaleit
Early spondyloarthritis.
Rheumatic diseases clinics of North America 2012;38(2):387-403.
2012: Martin Rudwaleit; Joachim Sieper
Referral strategies for early diagnosis of axial spondyloarthritis.
Nature reviews. Rheumatology 2012;8(5):262-8.
2012: Denis Poddubnyy; Joachim Sieper; Henning Zeidler; Jürgen Braun; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Martin Rudwaleit
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
Arthritis and rheumatism 2012;64(5):1388-98.
2012: Gisela Ruiz Heiland; Axel Hueber; Joachim Listing; Denis Poddubnyy; Martin Rudwaleit; Georg Schett; Heiner Appel; Xenofon Baraliakos; Hildrun Haibel; Jochen Zwerina; Joachim Sieper
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2012;71(4):572-4.
2011: Maxime Dougados; Bruno Fautrel; Antoine Feydy; Philippe Goupille; Véronique Leblanc; Isabelle Logeart; Thao Pham; Pascal Richette; Christian Roux; Martin Rudwaleit; Alain Saraux; Jean-Marc Treluyer; Désirée van der Heijde; Joelle Benessiano; Francis Berenbaum; Maxime Breban; Pascal Claudepierre; Bernard Combe; Maria-Antonietta d'Agostino; Patricia Dargent-Molina; Jean-Pierre Daurès; Daniel Wendling
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients.
Joint, bone, spine : revue du rhumatisme 2011;78(6):598-603.
2011: Denis Poddubnyy; Martin Rudwaleit; Beate Buss; Joachim Listing; Inge Spiller; Janis Vahldiek; Joachim Sieper
Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care.
The Journal of rheumatology 2011;38(11):2452-60.
2011: Denis A Poddubnyy; Joachim Sieper; Henning Zeidler; Jurgen Braun; Wiebke Kaluza-Schilling; Joachim Listing; Elisabeth Märker-Hermann; Martin Rudwaleit
Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
The Journal of rheumatology 2011;38(11):2436-41.
2011: Denis Poddubnyy; Martin Rudwaleit; Henning Zeidler; Jürgen Braun; Hildrun Haibel; Joachim Listing; Elisabeth Märker-Hermann; Joachim Sieper
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.
Annals of the rheumatic diseases 2011;70(8):1369-74.
2011: Denis Poddubnyy; Martin Rudwaleit
Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
Expert opinion on drug safety 2011;10(4):655-73.
2011: In-Ho Song; A Weiss; Christian E Althoff; B Freundlich; Hildrun Haibel; Kay-Geert A Hermann; Joachim Listing; D Poddubnyy; Martin Rudwaleit; Joachim Sieper
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.
Annals of the rheumatic diseases 2011;70(7):1257-63.
2011: Désirée van der Heijde; Jürgen Braun; Rubén Burgos-Vargas; Maxime Dougados; Robert Landewé; Walter P Maksymowych; Martin Rudwaleit; Joachim Sieper
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
Annals of the rheumatic diseases 2011;70(6):905-8.
2011: In-Ho Song; A Weiss; Jürgen Braun; Hildrun Haibel; F Heldmann; Martin Rudwaleit; Joachim Sieper
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.
Annals of the rheumatic diseases 2011;70(6):1108-10.
2011: Martin Rudwaleit; Désirée van der Heijde; R Landewé; N Akkoc; Jan Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; Euthalia Thalia Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; Joachim Sieper
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.
Annals of the rheumatic diseases 2011;70(1):25-31.
2011: Martin Rudwaleit; Katherine Gooch; Beat Michel; Manfred Herold; Ake Thörner; Robert Wong; Martina Kron; Naijun Chen; Hartmut Kupper
Adalimumab improves sleep and sleep quality in patients with active ankylosing spondylitis.
The Journal of rheumatology 2011;38(1):79-86.
2010: Désirée van der Heijde; Martin Rudwaleit; Robert B M Landewé; Jochen Sieper
Justification for including MRI as a tool in the diagnosis of axial SpA.
Nature reviews. Rheumatology 2010;6(11):670-2.
2010: Martin Rudwaleit; William J Taylor
Classification criteria for psoriatic arthritis and ankylosing spondylitis/axial spondyloarthritis.
Best practice & research. Clinical rheumatology 2010;24(5):589-604.
2010: Martin Rudwaleit
Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.
The Journal of rheumatology 2010;37(8):1553-5.
2010: Jürgen Braun; Martin Rudwaleit; Sonja Kary; Martina Kron; Robert L Wong; Hartmut Kupper
Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis.
Rheumatology (Oxford, England) 2010;49(8):1578-89.
2010: D A Poddubnyy; Martin Rudwaleit; Joachim Listing; Jürgen Braun; Joachim Sieper
Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Annals of the rheumatic diseases 2010;69(7):1338-41.
2010: Martin Rudwaleit
New approaches to diagnosis and classification of axial and peripheral spondyloarthritis.
Current opinion in rheumatology 2010;22(4):375-80.
2010: Georg Schett; Martin Rudwaleit
Can we stop progression of ankylosing spondylitis?
Best practice & research. Clinical rheumatology 2010;24(3):363-71.
2010: In-Ho Song; Henning Brandt; Martin Rudwaleit; Joachim Sieper
Limited diagnostic value of unilateral sacroiliitis in scintigraphy in assessing axial spondyloarthritis.
The Journal of rheumatology 2010;37(6):1200-2.
2010: In-Ho Song; F Heldmann; Martin Rudwaleit; Joachim Listing; Heiner Appel; Jürgen Braun; Joachim Sieper
Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.
Arthritis and rheumatism 2010;62(5):1290-7.
2010: Martin Rudwaleit; Filip Van den Bosch; Martina Kron; Sonja Kary; Hartmut Kupper
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.
Arthritis research & therapy 2010;12(3):R117.
2010: Martin Rudwaleit; Pascal Claudepierre; Martina Kron; Sonja Kary; Robert Wong; Hartmut Kupper
Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.
Arthritis research & therapy 2010;12(2):R43.
2009: Denis A Poddubnyy; Martin Rudwaleit
Adalimumab for the treatment of psoriatic arthritis.
Expert review of clinical immunology 2009;5(6):671-81.
2009: Heiner Appel; Gisela Ruiz-Heiland; Joachim Listing; Jochen Zwerina; Martin Herrmann; Ruediger Mueller; Hildrun Haibel; Xenofon Baraliakos; Axel Hempfing; Martin Rudwaleit; Joachim Sieper; Georg Schett
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.
Arthritis and rheumatism 2009;60(11):3257-62.
2009: In-Ho Song; Martin Rudwaleit; J Listing; Joachim Sieper
Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.
Annals of the rheumatic diseases 2009;68(11):1701-7.
2009: Joachim Sieper; Martin Rudwaleit; Xenofon Baraliakos; Jan Brandt; Jürgen Braun; R Burgos-Vargas; M Dougados; Kay-Geert A Hermann; R Landewé; W Maksymowych; Désirée van der Heijde
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.
Annals of the rheumatic diseases 2009;68 Suppl 2():ii1-44.
2009: Martin Rudwaleit; R Landewé; Désirée van der Heijde; Joachim Listing; Jan Brandt; Jürgen Braun; R Burgos-Vargas; E Collantes-Estevez; J Davis; B Dijkmans; M Dougados; P Emery; I E van der Horst-Bruinsma; R Inman; M A Khan; M Leirisalo-Repo; S van der Linden; W P Maksymowych; H Mielants; I Olivieri; R Sturrock; K de Vlam; Joachim Sieper
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.
Annals of the rheumatic diseases 2009;68(6):770-6.
2009: Martin Rudwaleit; Désirée van der Heijde; R Landewé; Joachim Listing; N Akkoc; Jan Brandt; Jürgen Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; Salih Ozgocmen; Euthalia Thalia Roussou; R Valle-Oñate; U Weber; J Wei; Joachim Sieper
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
Annals of the rheumatic diseases 2009;68(6):777-83.
2009: Joachim Sieper; Désirée van der Heijde; R Landewé; Jan Brandt; R Burgos-Vagas; E Collantes-Estevez; B Dijkmans; M Dougados; M A Khan; M Leirisalo-Repo; S van der Linden; W P Maksymowych; H Mielants; I Olivieri; Martin Rudwaleit
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
Annals of the rheumatic diseases 2009;68(6):784-8.
2009: Martin Rudwaleit; Ignazio Olivieri; Kyriaki A Boki; Eduard N Griep; Pentti Järvinen; Robert L Wong; Martina Kron; Sonja Kary; Hartmut Kupper
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.
Rheumatology (Oxford, England) 2009;48(5):551-7.
2009: Martin Rudwaleit; E Rødevand; P Holck; J Vanhoof; M Kron; Sonja Kary; Hartmut Kupper
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.
Annals of the rheumatic diseases 2009;68(5):696-701.
2009: Martin Rudwaleit; Pascal Claudepierre; Paul Wordsworth; Eduardo Loza Cortina; Joachim Sieper; Martina Kron; Roberto Carcereri-De-Prati; Hartmut Kupper; Sonja Kary
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis.
The Journal of rheumatology 2009;36(4):801-8.
2009: Martin Rudwaleit; Hildrun Haibel; Xenofon Baraliakos; Joachim Listing; Elisabeth Märker-Hermann; Henning Zeidler; Jürgen Braun; Joachim Sieper
The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.
Arthritis and rheumatism 2009;60(3):717-27.
2008: Heiner Appel; Martin Rudwaleit; Joachim Sieper
Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis.
Nature clinical practice. Rheumatology 2008;4(11):578-9.
2008: In-Ho Song; J Carrasco-Fernández; Martin Rudwaleit; Joachim Sieper
The diagnostic value of scintigraphy in assessing sacroiliitis in ankylosing spondylitis: a systematic literature research.
Annals of the rheumatic diseases 2008;67(11):1535-40.
2008: Martin Rudwaleit; S Schwarzlose; E S Hilgert; Joachim Listing; Jürgen Braun; Joachim Sieper
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
Annals of the rheumatic diseases 2008;67(9):1276-81.
2008: Hildrun Haibel; Martin Rudwaleit; Joachim Listing; Frank Heldmann; Robert L Wong; Hartmut Kupper; Jürgen Braun; Joachim Sieper
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two.
Arthritis and rheumatism 2008;58(7):1981-91.
2008: In-Ho Song; D A Poddubnyy; Martin Rudwaleit; Joachim Sieper
Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.
Arthritis and rheumatism 2008;58(4):929-38.
2008: Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R Grün; Marta Steinbrich-Zöllner; Marina Backhaus; Thomas Häupl; Martin Rudwaleit; Gabriela Riemekasten; Andreas Radbruch; Falk Hiepe; Gerd-Rüdiger Burmester; Andreas Grützkau
Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Arthritis and rheumatism 2008;58(4):1136-45.
2008: Marta Steinbrich-Zöllner; Joachim R Grün; Toralf Kaiser; Robert Biesen; Katharina Raba; Peihua Wu; Andreas Thiel; Martin Rudwaleit; Joachim Sieper; Gerd-Rüdiger Burmester; Andreas Radbruch; Andreas Grützkau
From transcriptome to cytome: integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2008;73(4):333-40.
2008: Hildrun Haibel; In-Ho Song; Martin Rudwaleit; Joachim Listing; S Hildemann; Joachim Sieper
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.
Clinical and experimental rheumatology 2008;26(2):247-52.
2008: Joachim Sieper; Heiner Appel; Jürgen Braun; Martin Rudwaleit
Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes.
Arthritis and rheumatism 2008;58(3):649-56.
2008: In-Ho Song; Heiner Appel; Hildrun Haibel; Christoph Loddenkemper; Jurgen Braun; Joachim Sieper; Martin Rudwaleit
New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
The Journal of rheumatology 2008;35(3):532-6.
2008: Heiner Appel; Louise Janssen; Joachim Listing; René Heydrich; Martin Rudwaleit; Joachim Sieper
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
Arthritis research & therapy 2008;10(5):R125.
2008: Xenofon Baraliakos; Joachim Listing; Martin Rudwaleit; Joachim Sieper; Juergen Braun
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.
Arthritis research & therapy 2008;10(5):R104.
2008: Martin Rudwaleit
[Early diagnosis of ankylosing spondylitis and spondyolarthritis and predictors of outome].
Wiener medizinische Wochenschrift (1946) 2008;158(7-8):186-90.
2007: Heiner Appel; Kay-Geert A Hermann; Christian E Althoff; Martin Rudwaleit; Joachim Sieper
Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.
The Journal of rheumatology 2007;34(12):2497-8.
2007: Heiner Appel; Rebecca Scheer; Hildrun Haibel; Peihua Wu; Inge Spiller; Henning Christian Brandt; In-Ho Song; Martin Rudwaleit; Andreas Thiel; Joachim Sieper
In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis.
The Journal of rheumatology 2007;34(11):2264-70.
2007: Henning Christian Brandt; Inge Spiller; In-Ho Song; Janis L Vahldiek; Martin Rudwaleit; Joachim Sieper
Performance of referral recommendations in patients with chronic back pain and suspected axial spondyloarthritis.
Annals of the rheumatic diseases 2007;66(11):1479-84.
2007: In-Ho Song; Joachim Sieper; Martin Rudwaleit
Diagnosing early ankylosing spondylitis.
Current rheumatology reports 2007;9(5):367-74.
2007: Xenofon Baraliakos; Joachim Listing; Jan Brandt; Hildrun Haibel; Martin Rudwaleit; Joachim Sieper; Jürgen Braun
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
Rheumatology (Oxford, England) 2007;46(9):1450-3.
2007: Christian E Althoff; Heiner Appel; Martin Rudwaleit; Joachim Sieper; Iris Eshed; Bernd Hamm; Kay-Geert A Hermann
Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis.
Annals of the rheumatic diseases 2007;66(7):983-5.
2007: Xenofon Baraliakos; Joachim Listing; Martin Rudwaleit; Hildrun Haibel; Jan Brandt; Joachim Sieper; Jürgen Braun
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes.
Annals of the rheumatic diseases 2007;66(7):910-5.
2007: Jürgen Braun; Xenofon Baraliakos; Joachim Listing; J Davis; Désirée van der Heijde; Hildrun Haibel; Martin Rudwaleit; Joachim Sieper
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
Arthritis and rheumatism 2007;57(4):639-47.
2007: Martin Rudwaleit; Joachim Sieper
A case of axial undifferentiated spondyloarthritis diagnosis and management.
Nature clinical practice. Rheumatology 2007;3(5):298-303.
2007: Joachim Sieper; Martin Rudwaleit; Jürgen Braun
Adalimumab for the treatment of ankylosing spondylitis.
Expert opinion on pharmacotherapy 2007;8(6):831-8.
2007: Désirée van der Heijde; Robert Landewé; Kay-Geert A Hermann; Martin Rudwaleit; Mikkel Østergaard; Ans Oostveen; Phil O'Connor; Walter P Maksymowych; Robert G W Lambert; cedric lukas; Anne Grethe Jurik; Maarten Boers; Xenofon Baraliakos; Jürgen Braun
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?
The Journal of rheumatology 2007;34(4):871-3.
2007: cedric lukas; Jürgen Braun; Désirée van der Heijde; Kay-Geert A Hermann; Martin Rudwaleit; Mikkel Østergaard; Ans Oostveen; Phil O'Connor; Walter P Maksymowych; Robert G W Lambert; Anne Grethe Jurik; Xenofon Baraliakos; Robert Landewé
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
The Journal of rheumatology 2007;34(4):862-70.
2007: Xenofon Baraliakos; Joachim Listing; Martin Rudwaleit; Jan Brandt; RIEKE ALTEN; Gerd R Burmester; Erika Gromnica-Ihle; Hildrun Haibel; Stephan Schewe; Matthias Schneider; Helmut Sörensen; Henning Zeidler; Sudha Visvanathan; Joachim Sieper; Juergen Braun
Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
The Journal of rheumatology 2007;34(3):510-5.
2007: Hildrun Haibel; Henning Christian Brandt; In-Ho Song; A Brandt; Joachim Listing; Martin Rudwaleit; Joachim Sieper
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial.
Annals of the rheumatic diseases 2007;66(3):419-21.
2006: Sascha Al Dahouk; Thomas Schneider; Andreas Jansen; Karsten Nöckler; Herbert Tomaso; Ralf M Hagen; Holger C Scholz; Martin Rudwaleit; Heinrich Neubauer; Andreas J Morguet
Brucella endocarditis in prosthetic valves.
The Canadian journal of cardiology 2006;22(11):971-4.
2006: Heiner Appel; Maren Kuhne; Simone Spiekermann; Harald Ebhardt; Zarko Grozdanovic; Dorothee Köhler; Marc Dreimann; Axel Hempfing; Martin Rudwaleit; Harald Stein; Peter Metz-Stavenhagen; Joachim Sieper; Christoph Loddenkemper
Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis.
Arthritis and rheumatism 2006;54(9):2845-51.
2006: Martin Rudwaleit; Dominique Baeten
Ankylosing spondylitis and bowel disease.
Best practice & research. Clinical rheumatology 2006;20(3):451-71.
2006: Joachim Sieper; Martin Rudwaleit; Muhammed Asim Khan; Jürgen Braun
Concepts and epidemiology of spondyloarthritis.
Best practice & research. Clinical rheumatology 2006;20(3):401-17.
2006: Carsten Tschöpe; Dirk Westermann; Paul Steendijk; Mario Kasner; Martin Rudwaleit; Peter L Schwimmbeck; Wolfgang Poller; Heinz-Peter Schultheiss
Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenon.
Clinical research in cardiology : official journal of the German Cardiac Society 2006;95(6):344-8.
2006: Hildrun Haibel; Martin Rudwaleit; Henning Christian Brandt; Zarko Grozdanovic; Joachim Listing; Hartmut Kupper; Jürgen Braun; Joachim Sieper
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
Arthritis and rheumatism 2006;54(2):678-81.
2006: Martin Rudwaleit; Anke Metter; Joachim Listing; Joachim Sieper; Jürgen Braun
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.
Arthritis and rheumatism 2006;54(2):569-78.
2006: Heiner Appel; Christoph Loddenkemper; Zarko Grozdanovic; Harald Ebhardt; Marc Dreimann; Axel Hempfing; Harald Stein; Peter Metz-Stavenhagen; Martin Rudwaleit; Joachim Sieper
Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis.
Arthritis research & therapy 2006;8(5):R143.
2005: Xenofon Baraliakos; Jan Brandt; Joachim Listing; Hildrun Haibel; Helmut Sörensen; Martin Rudwaleit; Joachim Sieper; Jürgen Braun
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
Arthritis and rheumatism 2005;53(6):856-63.
2005: Thomas Schneider; Christoph Loddenkemper; Martin Rudwaleit; Hartmut Lode; Martin Zeitz
[Fever of unknown origin in the 21st century. 2. Non-infectious diseases (autoimmune diseases)].
Deutsche medizinische Wochenschrift (1946) 2005;130(48):2774-8.
2005: Joachim Sieper; Xenofon Baraliakos; Joachim Listing; Jan Brandt; Hildrun Haibel; Martin Rudwaleit; Jürgen Braun
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
Rheumatology (Oxford, England) 2005;44(12):1525-30.
2005: Thomas Schneider; Christoph Loddenkemper; Martin Rudwaleit; Hartmut Lode; Martin Zeitz
[Fever of unknown origin in the 21st century: infectious diseases].
Deutsche medizinische Wochenschrift (1946) 2005;130(47):2708-12.
2005: S Kohler; Andreas Thiel; Martin Rudwaleit; Joachim Sieper; Jürgen Braun
CD27+ memory and CD27- effector CD8+ T cells are responsible for a decreased production of proinflammatory cytokines in HLA B27-positive subjects.
Clinical and experimental rheumatology 2005;23(6):840-6.
2005: Martin Rudwaleit; Joachim Sieper
[Early diagnosis of spondyloarthritis with special attention to the axial forms].
Zeitschrift für Rheumatologie 2005;64(8):524-30.
2005: Joachim Sieper; Martin Rudwaleit
[Early diagnosis of rheumatic diseases--relevance and challenges].
Zeitschrift für Rheumatologie 2005;64(8):513-5.
2005: Joachim Sieper; Martin Rudwaleit
How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
Annals of the rheumatic diseases 2005;64 Suppl 4():iv61-4.
2005: Robert B M Landewé; Kay-Geert A Hermann; Désirée van der Heijde; Xenofon Baraliakos; Anne Grethe Jurik; Robert G W Lambert; Mikkel Østergaard; Martin Rudwaleit; David Salonen; Jürgen Braun
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
The Journal of rheumatology 2005;32(10):2050-5.
2005: Désirée van der Heijde; Robert B M Landewé; Kay-Geert A Hermann; Anne Grethe Jurik; Walter P Maksymowych; Martin Rudwaleit; Philip J O'Connor; Jürgen Braun
Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
The Journal of rheumatology 2005;32(10):2042-7.
2005: Xenofon Baraliakos; Joachim Listing; Martin Rudwaleit; Jan Brandt; Joachim Sieper; Jürgen Braun
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
Annals of the rheumatic diseases 2005;64(10):1462-6.
2005: Martin Rudwaleit; Xenofon Baraliakos; Joachim Listing; Jan Brandt; Joachim Sieper; Jürgen Braun
Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Annals of the rheumatic diseases 2005;64(9):1305-10.
2005: Martin Rudwaleit; Joachim Sieper
[Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
Deutsche medizinische Wochenschrift (1946) 2005;130(33):1882-6.
2005: Martin Rudwaleit; Joachim Sieper
Infliximab for the treatment of ankylosing spondylitis.
Expert opinion on biological therapy 2005;5(8):1095-109.
2005: Xenofon Baraliakos; Kay-Geert A Hermann; Robert Landewé; Joachim Listing; W Golder; Jan Brandt; Martin Rudwaleit; Matthias Bollow; Joachim Sieper; Désirée van der Heijde; Jürgen Braun
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.
Annals of the rheumatic diseases 2005;64(8):1141-4.
2005: J Zou; Heiner Appel; Martin Rudwaleit; Andreas Thiel; Joachim Sieper
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis.
Annals of the rheumatic diseases 2005;64(5):722-9.
2005: Joachim Sieper; Martin Rudwaleit
Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.
Annals of the rheumatic diseases 2005;64(5):659-63.
2005: Xenofon Baraliakos; Robert Landewé; Kay-Geert A Hermann; Joachim Listing; W Golder; Jan Brandt; Martin Rudwaleit; Matthias Bollow; Joachim Sieper; Désirée van der Heijde; Jürgen Braun
Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging.
Annals of the rheumatic diseases 2005;64(5):730-4.
2005: Martin Rudwaleit; Muhammad A Khan; Joachim Sieper
The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?
Arthritis and rheumatism 2005;52(4):1000-8.
2005: Jan Brandt; Joachim Listing; Hildrun Haibel; Helmut Sörensen; A Schwebig; Martin Rudwaleit; Joachim Sieper; Jürgen Braun
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
Rheumatology (Oxford, England) 2005;44(3):342-8.
2005: Hildrun Haibel; Martin Rudwaleit; Joachim Listing; Joachim Sieper
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.
Annals of the rheumatic diseases 2005;64(2):296-8.
2005: Xenofon Baraliakos; Joachim Listing; Jan Brandt; Angela Zink; RIEKE ALTEN; Gerd R Burmester; Erika Gromnica-Ihle; Herbert Kellner; Matthias Schneider; Helmut Sörensen; Henning Zeidler; Martin Rudwaleit; Joachim Sieper; Juergen Braun
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Arthritis research & therapy 2005;7(3):R439-44.
2005: Hildrun Haibel; Martin Rudwaleit; Jürgen Braun; Joachim Sieper
Six months open label trial of leflunomide in active ankylosing spondylitis.
Annals of the rheumatic diseases 2005;64(1):124-6.
2004: Joachim Listing; J Brandt; Martin Rudwaleit; Angela Zink; Joachim Sieper; Jürgen Braun
Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2004;63(12):1670-2.
2004: Jan Brandt; Joachim Listing; Joachim Sieper; Martin Rudwaleit; Désirée van der Heijde; Jürgen Braun
Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.
Annals of the rheumatic diseases 2004;63(11):1438-44.
2004: Hildrun Haibel; Martina Niewerth; J Brandt; Martin Rudwaleit; Joachim Listing; Joachim Sieper; Jürgen Braun
[Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab-a comparison of SF-36 and SF-12].
Zeitschrift für Rheumatologie 2004;63(5):393-401.
2004: Heiner Appel; Lucia Neure; Maren Kuhne; Jürgen Braun; Martin Rudwaleit; Joachim Sieper
An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.
Clinical rheumatology 2004;23(5):435-40.
2004: Jürgen Braun; Xenofon Baraliakos; W Golder; Kay-Geert A Hermann; Joachim Listing; Jan Brandt; Martin Rudwaleit; S Zuehlsdorf; Matthias Bollow; Joachim Sieper; Désirée van der Heijde
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems.
Annals of the rheumatic diseases 2004;63(9):1046-55.
2004: Hildrun Haibel; Martin Rudwaleit; Joachim Sieper; Henning Zeidler; J G Kuipers
[Diagnosis of reactive arthritis].
Zeitschrift für Rheumatologie 2004;63(3):211-5.
2004: Martin Rudwaleit; Joachim Sieper
[Diagnosis and early diagnosis of ankylosing spondylitis].
Zeitschrift für Rheumatologie 2004;63(3):193-202.
2004: Martin Rudwaleit; Joachim Listing; Jan Brandt; Jürgen Braun; Joachim Sieper
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.
Annals of the rheumatic diseases 2004;63(6):665-70.
2004: Martin Rudwaleit; Désirée van der Heijde; M A Khan; Jürgen Braun; Joachim Sieper
How to diagnose axial spondyloarthritis early.
Annals of the rheumatic diseases 2004;63(5):535-43.
2004: Jan Brandt; Andre Khariouzov; Joachim Listing; Hildrun Haibel; Helmut Sörensen; Martin Rudwaleit; Joachim Sieper; Jurgen Braun
Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
The Journal of rheumatology 2004;31(3):531-8.
2003: Juergen Braun; Jan Brandt; Joachim Listing; Martin Rudwaleit; Joachim Sieper
Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
Current opinion in rheumatology 2003;15(4):394-407.
2003: J Zou; Y Zhang; Andreas Thiel; Martin Rudwaleit; S-L Shi; Andreas Radbruch; R Poole; Jürgen Braun; Joachim Sieper
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
Rheumatology (Oxford, England) 2003;42(7):846-55.
2003: Jan Brandt; A Khariouzov; Joachim Listing; Hildrun Haibel; Helmut Sörensen; L Grassnickel; Martin Rudwaleit; Joachim Sieper; Jürgen Braun
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Arthritis and rheumatism 2003;48(6):1667-75.
2003: Jürgen Braun; Xenofon Baraliakos; W Golder; Jan Brandt; Martin Rudwaleit; Joachim Listing; Matthias Bollow; Joachim Sieper; Désirée van der Heijde
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
Arthritis and rheumatism 2003;48(4):1126-36.
2003: Jianxiang Zou; Martin Rudwaleit; Jan Brandt; Andreas Thiel; Jürgen Braun; Joachim Sieper
Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Arthritis and rheumatism 2003;48(3):780-90.
2003: Heiner Appel; Christoph Loddenkemper; Peter Schirmacher; Hans Peter Dienes; Joachim Sieper; Martin Rudwaleit; Werner Golder; Martin Zeitz
Congenital absence of the portal vein with splenomegaly and hypersplenism in a young woman.
Digestion 2003;67(1-2):105-10.
2002: Joachim Sieper; Jürgen Braun; Martin Rudwaleit; A Boonen; A Zink
Ankylosing spondylitis: an overview.
Annals of the rheumatic diseases 2002;61 Suppl 3():iii8-18.
2002: Martin Rudwaleit; B Andermann; RIEKE ALTEN; Helmut Sörensen; Joachim Listing; Angela Zink; Joachim Sieper; J Braun
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis.
Annals of the rheumatic diseases 2002;61(11):968-74.
2002: Heiner Appel; Christoph Loddenkemper; Janine Rohweder; Martin Rudwaleit; Martin Zeitz; Joachim Sieper
Massive splenomegaly and hypersplenism in a young woman with primary Sjögren's syndrome.
The Journal of rheumatology 2002;29(9):2012-3.
2002: Heiner Appel; Martin Rudwaleit; P Wu; M Grolms; Joachim Sieper; AK Mertz
Synovial T cell proliferation to the Yersinia enterocolitica 19 kDa antigen differentiates yersinia triggered reactive arthritis (ReA) from ReA triggered by other enterobacteria.
Annals of the rheumatic diseases 2002;61(6):566-7.
2002: Hildrun Haibel; Martin Rudwaleit; Jürgen Braun; Joachim Sieper
[Epidemiology and patient management in the area of spondyloarthritis].
Zeitschrift für Rheumatologie 2002;61(1):30-8.
2002: Joachim Sieper; Martin Rudwaleit; Jürgen Braun; Désirée van der Heijde
Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.
Arthritis and rheumatism 2002;46(2):319-27.
2002: Jan Brandt; T Maier; Martin Rudwaleit; U Kühl; Falk Hiepe; Joachim Sieper; Jürgen Braun
Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis.
Clinical and experimental rheumatology 2002;20(1):80-4.
2002: U Machein; B Buss; Inge Spiller; Jürgen Braun; Martin Rudwaleit; L Faerber; Joachim Sieper
Effective treatment of early rheumatoid arthritis with a combination of methotrexate, prednisolone and cyclosporin.
Rheumatology (Oxford, England) 2002;41(1):110-1.
2001: Martin Rudwaleit; S Siegert; Z Yin; J Eick; Andreas Thiel; Andreas Radbruch; Joachim Sieper; Jürgen Braun
Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.
Annals of the rheumatic diseases 2001;60(1):36-42.
2000: V Moos; Martin Rudwaleit; V Herzog; K Höhlig; Joachim Sieper; B Müller
Association of genotypes affecting the expression of interleukin-1beta or interleukin-1 receptor antagonist with osteoarthritis.
Arthritis and rheumatism 2000;43(11):2417-22.
2000: Jürgen Braun; J Xiang; Jan Brandt; H Maetzel; Hildrun Haibel; P Wu; S Kohler; Martin Rudwaleit; S Siegert; Andreas Radbruch; Andreas Thiel; Joachim Sieper
Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
Annals of the rheumatic diseases 2000;59 Suppl 1():i85-9.
2000: Martin Rudwaleit; Z Yin; S Siegert; M Grolms; Andreas Radbruch; Jürgen Braun; Joachim Sieper
Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4.
Annals of the rheumatic diseases 2000;59(4):311-4.
2000: AK Mertz; P Wu; T Sturniolo; D Stoll; Martin Rudwaleit; Roland Lauster; Jürgen Braun; Joachim Sieper
Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1529-37.
1999: Jürgen Braun; Z Yin; Inge Spiller; S Siegert; Martin Rudwaleit; L Liu; Andreas Radbruch; Joachim Sieper
Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis.
Arthritis and rheumatism 1999;42(10):2039-44.
1999: Jan Brandt; Matthias Bollow; JH Häberle; Martin Rudwaleit; U Eggens; Armin Distler; Joachim Sieper; Jürgen Braun
Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.
Rheumatology (Oxford, England) 1999;38(9):831-6.
1998: Martin Rudwaleit; F Elias; T Humaljoki; Lucia Neure; W Knauf; H Stein; Armin Distler; Joachim Sieper; C Berek; Jürgen Braun
Overexpanded B cell clone mediating leukemic arthritis by abundant secretion of interleukin-1beta: a case report.
Arthritis and rheumatism 1998;41(9):1695-700.
1998: Jan Brandt; Martin Rudwaleit; U Eggens; AK Mertz; Armin Distler; Joachim Sieper; Jürgen Braun
Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy.
The Journal of rheumatology 1998;25(4):718-24.
1998: Jürgen Braun; Matthias Bollow; G Remlinger; U Eggens; Martin Rudwaleit; Armin Distler; Joachim Sieper
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.
Arthritis and rheumatism 1998;41(1):58-67.
1996: Martin Rudwaleit; A Schwarz; C Trautmann; Gerd Offermann; Armin Distler
Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapy.
American journal of nephrology 1996;16(4):344-8.